Drugs / Quadrivalent MDCK Inactivated Influenza Vaccine
Quadrivalent MDCK Inactivated Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT03553940 Background | Aug 2018 → Aug 2020 | influenza | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent MDCK Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03553940 ↗ |
| Modality | Vaccine | “A quadrivalent cell culture inactivated vaccine (ccIV4) is an inactivated subunit influenza vaccine” NCT03553940 ↗ |
| Route | Intramuscular | “Administered intramuscularly as a single dose.” NCT03553940 ↗ |